Multi Center Site , Controlled Trial Comparing a Bioengineered Skin Substitute to a Human Skin Allograft
NCT01676272 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23
Last updated 2019-06-26
Summary
Despite the widespread use of advanced biologics for the treatment of diabetic foot ulcers, data comparing one type of modality to another are scarce. This investigation is a prospective randomized study comparing a bioengineered skin substitute to a human skin allograft.
Conditions
- Diabetic Foot Ulcer
Sponsors & Collaborators
-
Solsys Medical LLC
lead INDUSTRY
Principal Investigators
-
Nelson Keller, DPM · Mary Immaculate Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2015-11-30
- Completion
- 2015-11-30
Countries
- United States
Study Locations
More Related Trials
-
Modified Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of Hard-to-Heal DFUs
NCT06449638 ·Status: RECRUITING ·Phase: NA
-
Study of Amniotic Membrane Graft in the Management of Diabetic Foot Ulcers
NCT02399826 ·Status: UNKNOWN ·Phase: NA
-
Postmarket Study to Evaluate Biovance® in Diabetic Foot Ulcers
NCT02506452 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial Evaluating an Amnion Membrane Allograft for Use in the Management of Non- Healing Diabetic Foot Ulcers Versus Standard Of Care
NCT06767501 ·Status: RECRUITING ·Phase: NA
-
AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers
NCT03547635 ·Status: COMPLETED ·Phase: NA
-
Allogenic Dermis Versus Standard Care in the Management of Diabetic Foot Ulcers
NCT02331147 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Dermal-Living Skin Replacement to Treat Diabetic Foot Ulcers
NCT00368693 ·Status: TERMINATED ·Phase: PHASE3
-
A Safety and Efficacy Study of INTEGRA® Dermal Regeneration Template for the Treatment of Diabetic Foot Ulcers
NCT01060670 ·Status: COMPLETED ·Phase: NA
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
NCT07086443 ·Status: RECRUITING ·Phase: PHASE4
-
A Comparison of TCC-EZ Using Human Amnion Allograft vs TCC-EZ and Standard Wound Care in Treating Diabetic Foot Ulcers.
NCT02344329 ·Status: UNKNOWN ·Phase: PHASE4
-
ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers
NCT02657876 ·Status: COMPLETED ·Phase: PHASE1
-
Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers
NCT01181440 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds
NCT03662997 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds
NCT07223892 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Comparison of Human Allograft to Apligraf for Venous Leg Ulcers
NCT02047084 ·Status: ENROLLING_BY_INVITATION
-
Study of SANTYL® vs Hydrogel (SoloSite®) for Pressure Ulcers
NCT02718625 ·Status: TERMINATED ·Phase: PHASE4
-
Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care
NCT03626623 ·Status: TERMINATED ·Phase: NA
-
Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers
NCT01181453 ·Status: COMPLETED ·Phase: PHASE3
-
Use of INTEGRA™ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
NCT01108263 ·Status: TERMINATED ·Phase: PHASE4
-
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
NCT01858545 ·Status: TERMINATED ·Phase: NA
-
Acellular Dermal Allograft for Chronic Diabetic Wounds
NCT06227520 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Enzymatic Versus (vs) Autolytic Debridement of Diabetic Foot Ulcers
NCT01143727 ·Status: COMPLETED ·Phase: PHASE4
-
Bio-ConneKt Wound Dressing for Treatment of Chronic Leg Wounds: A Pilot Study
NCT02309684 ·Status: UNKNOWN
-
Bioengineered Skin and Wound Healing
NCT00007280 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study in the Treatment of Chronic Diabetic Foot Ulcers
NCT00387101 ·Status: TERMINATED ·Phase: PHASE3